3 new cases of COVID-19 out of 399 tested

211

Three (3) new cases of COVID-19 were identified out of 399 tests performed on Wednesday, March 31. To date, there have been a total of 7,810 officially reported cases of COVID-19 with 134 deaths, 27 cases in active isolation, and 7,649 not in active isolation. Three (3) cases reported recent travel history and were identified in quarantine.

TODAY’S CAR SCORE

0.2

The COVID Area Risk (CAR) Score accounts for the incidence of new cases, how well current testing identifies these cases, and the rate of spread. The ideal long-term goal is to sustain a CAR Score of 2.5 or less, which has been shown to correlate with very low to zero COVID-related hospitalizations and deaths.

The following tables provide COVID-19 test results from Wednesday, March 31:

COVID-19 CASE COUNT

TOTAL

NEW CASES REPORTED TODAY

PAST 7 DAYS

COVID-19 CASES:

7,810

3

16

CONFIRMED CASES:

7,600

3

16

PROBABLE CASES:

210

0

0

 

COVID-19 TESTING

ON GUAM

TOTAL

NEW TESTS

REPORTED TODAY

7-DAY

% POSITIVE

DIAGNOSTIC TESTS

141,412

399

1%

MOLECULAR TESTS

131,169

389

1%

ANTIGEN TEST

10,243

10

0%

SEROLOGY TESTS

366

1

0%

 

CASE BREAKDOWN

STATUS

TOTAL

CURRENT ISOLATION LOCATION

TOTAL

COVID-19 Death

134

Hospital

2

Active Isolation

27

Home

10

Not In Isolation

7,649

Isolation Facility

7

Civilian

7,405

Military

8

Military Service Member

405

 

COVID HOSPITAL CENSUS

Guam Memorial Hospital

Guam Regional Medical City

U.S. Naval Hospital

TOTAL

COVID ADMISSION

1

1

0

2

IN ICU

0

0

0

0

ON VENTILATOR

0

0

0

0

 

Preliminary COVID-19 vaccinations administered from December 17 to March 31:

Vaccine Maker

1st Doses Administered

2nd Doses Administered

Fully Immunized

Pfizer-BioNTech

34,070

16,431*

16,431

Moderna

19,322**

15,229***

15,229

Johnson & Johnson Janssen

77****

TOTALS:

53,392

31,660

31,737

*Administering second doses of Pfizer-BioNTech COVID-19 vaccinations began on January 4, 2021.

**Administering first doses of Moderna COVID-19 vaccinations began on January 8, 2021.

***Administering second doses of Moderna COVID-19 vaccinations began on January 29, 2021.

****Johnson &Johnson/Janssen COVID-19 vaccinations began on March 15 and were developed as a one-dose series.

 

Total Doses Administered

Total Doses Allotted

% Administered

Doses Remaining

85,129^

87,860^^

96.89%

2,731

^As of March 31, 2021. Total doses administered and allotted doses differ as vaccinators were able to draw additional doses per vial. Additionally, the U.S. Food and Drug Administration’s February 25, 2021 revision of their Fact Sheet relative to the Pfizer-BioNTech Emergency Use Authorization now states, “After dilution, one vial contains six doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains five doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons.” | ^^Reflects the previous allocation total of 86,560 and last received an allocation of 1,300 Johnson & Johnson Janssen vaccines on March 8, 2021.

(JIC Release No. 621)

##